We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Technology

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What is the Cyberknife®?

By Toni Henthorn
Updated: May 17, 2024
Views: 4,480
Share

Developed in 1990, the Cyberknife® is a device that targets radiation therapy to a clearly defined therapeutic site more accurately than traditional radiotherapy. The two main components of the system are a small linear particle accelerator and a robotic arm. With the radiation source mounted to a robot, radiation therapy can be directed at a well-delineated anatomic site from a variety of directions and angles, with instant repositioning possible. X-ray image guidance helps the Cyberknife® accurately target tumors and other masses. Radiotherapists currently use the Cyberknife® to treat a variety of benign and malignant tumors, as well as other medical ailments.

The United States Food and Drug Administration (FDA) first approved the Cyberknife® for treatment of tumors in any body location in August 2001. Since its clearance, the system has been effectively used to treat multiple cancers, including tumors of the pancreas, liver, prostate, and spine. The system has not resulted in improved patient survival compared to that of conventional therapy. Because it is more accurate, however, the device lets doctors deliver of a higher dose of radiation in a shorter period with less collateral damage to normal tissue than would be possible with conventional therapy.

The Cyberknife® is unique among all of the radiosurgical devices in that it does not require a rigid frame for precise targeting. Conventional systems rely upon the connection of frames to a patient's skull with aluminum or titanium screws in order to ensure accurate radiation delivery. By comparison, the frame-free system of the Cyberknife® facilitates fast and precise treatment delivery by comparing on-the-fly image guidance X-rays to previously obtained computed tomography scans, allowing accurate correlation and specific patient repositioning on the robotic treatment bed, the RoboCouch®. This allows the possibility of dispensing the radiation dose over several days or weeks, a process called fractionation. Fractionation allows the healthy tissues to repair themselves while the tumor cells, with faulty repair mechanisms, continue to die.

Sold by a United States company, Accuray, the Cyberknife® is operational in approximately 150 locations worldwide, with 100 treatment facilities in the United States alone. About 40,000 patients have been treated with the system worldwide. The actor Patrick Swayze received radiation treatments for his pancreatic cancer using the Cyberknife® technology in 2008. Located near its development site, the first Cyberknife® unit was set up outside of Stanford University at Newport Diagnostic Center in Newport Beach, California. Stanford University has administered radiotherapy to more than 2,500 patients with the system.

Share
WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Editors' Picks

Discussion Comments
Share
https://www.wisegeek.net/what-is-the-cyberknife.htm
Copy this link
WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.